Although speculative, this could be the case, since the increase of SOM+ and/or NPY+ interneurons failed to occur in the same T2D mice where we also observed decreased neurological recovery (previously published in the first part of this study in Pintana et al. (2019). The gene discussed is NPY; the disease is type 2 diabetes mellitus.